Worthington emcees for Tour
Deschutes, backs grass roots cancer
survivorship support program
Founded in 2005 by Gary Bonackker
to raise money for the Lance
Armstrong Foundation, the
Tour Deschutes in Bend, Oregon
is a cycling event that is on target
this year to raise over $100,000 for
St. Charles Hospital's "Defeat
Cancer" survivorship program
with support from organizations such
as the
Punch Worthington Lab.
According to Peggy Carey, Cancer
Program Director for Cascade
Healthcare Community, 10 million
people in the U.S are living with
cancer, with 8,500 in the Central
and Eastern Oregon region alone.
Survivorship programs support those
affected by cancer, and the Tour
Deschutes has funded a coordinator
for the St. Charles program that
puts area survivors in touch with
similarly situated patients.
The Cancer Survivorship Program
provides Central and Eastern
Oregonians with a history of cancer
the opportunity to access
supportive, life-affirming programs.
A generous donation from the Tour
Deschutes organization helped
establish the Survivorship Program
in 2007, matching newly diagnosed
patients of any cancer and their
caregivers with trained volunteers
who have survived similar
experiences.
Survivors counsel other patients
and help them navigate the medical
world. These "navigators" and their
friends include hundreds of
cyclists, all volunteers, who are
raising money and awareness in Bend.
They have developed a huge database
of cancer patients, which means that
matches can be made easier and more
quickly. Patients with the same
disease, same stage, and who live in
the same area can network to
overcome the significant hurdles in
cancer treatment, care, and coping.
St. Charles, through the grant
funded by Tour Deschutes, has
trained 34 sponsors as volunteers
for the network. Our law firm's
support for this event emphasizes
our commitment to help people get
support through networks and
survivorship. The expansion of
navigators for each tumor is the
goal: giving help and hope to
others. With research and better
treatment, we hope that victims of
lung related cancers will one day
have the same chance of survivorship
as those with breast, prostate, and
other cancers.